タカラバイオJP:4974
時価総額
¥924.8億
PER
-10.3倍
試薬、機器、受託、遺伝子医療の各事業を展開し、PCR技術や遺伝子治療薬、再生医療製品の製造・販売を手がける企業。
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| 現金同等物 | - | 20,584 | 19,384 | 28,078 | 17,537 | 17,033 | 18,266 | 25,993 | 23,633 | 51,847 | 35,416 | 29,549 |
| 有価証券 | - | 3,299 | 9,721 | 2,000 | 2,000 | 2,000 | 2,000 | - | - | - | - | - |
| 売掛金 | - | 6,741 | 6,830 | 7,455 | 8,031 | 8,604 | 9,102 | 12,626 | - | - | - | - |
| 商品及び製品 | - | 3,560 | 3,822 | 4,032 | 4,484 | 4,523 | 4,511 | 4,966 | 18,966 | 6,248 | 6,784 | 6,794 |
| 流動資産合計 | - | 36,447 | 42,158 | 43,964 | 35,032 | 35,275 | 38,387 | 49,115 | 68,141 | 77,569 | 62,759 | 57,679 |
| 有形固定資産 | - | 20,532 | 20,534 | 19,577 | 18,534 | 21,404 | 24,213 | 29,766 | 36,395 | 40,956 | 49,075 | 56,954 |
| 固定資産合計 | - | 29,978 | 24,432 | 23,178 | 33,821 | 35,765 | 36,622 | 40,635 | 47,571 | 51,632 | 58,492 | 67,655 |
| 総資産 | - | 66,425 | 66,591 | 67,143 | 68,854 | 71,040 | 75,009 | 89,750 | 115,712 | 129,202 | 121,252 | 125,334 |
| 買掛金 | - | 1,939 | 1,690 | 1,944 | 1,875 | 1,536 | 1,027 | 2,077 | 1,959 | 2,323 | 1,543 | 1,652 |
| 短期借入金 | - | 57 | 63 | 47 | - | - | - | - | - | - | - | - |
| 流動負債合計 | - | 5,439 | 5,430 | 6,025 | 5,745 | 6,017 | 6,248 | 13,191 | 17,380 | 14,375 | 7,168 | 7,131 |
| 長期借入金 | - | 178 | 130 | 82 | - | - | - | - | - | - | - | - |
| 固定負債合計 | - | 1,343 | 1,050 | 1,131 | 1,149 | 927 | 2,169 | 2,256 | 2,266 | 2,372 | 2,299 | 2,353 |
| 総負債 | - | 6,783 | 6,480 | 7,157 | 6,894 | 6,945 | 8,418 | 15,448 | 19,647 | 16,747 | 9,467 | 9,485 |
| 資本金及び資本剰余金 | - | 47,858 | 47,858 | 47,858 | 47,858 | 47,858 | 47,858 | 47,858 | 47,858 | 47,858 | 47,858 | 47,858 |
| 利益剰余金 | - | 8,142 | 9,295 | 10,432 | 12,285 | 15,401 | 18,501 | 27,085 | 45,009 | 57,047 | 53,471 | 52,465 |
| 株主資本 | 57,127 | 59,642 | 60,110 | 59,985 | 61,959 | 64,095 | 66,591 | 74,302 | 96,064 | 112,454 | 111,784 | 115,849 |